Therapeutic Radiopharmaceuticals Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026
ID : RI_
78102 | Date :
Jun, 2020 | Pages :
161 | Region : Global |
Publisher : RI
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The Global Therapeutic Radiopharmaceuticals Market size was xxx million USD with a CAGR xx % from 2015- 2019. It will stretch to xxx million USD in 2020 with a CAGR of xx % from 2020 - 2026.
As the report focuses on global Therapeutic Radiopharmaceuticals Market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the Market on the basis of regions, manufacturers, applications, and type.
in addition, this report introduces Market competition situation among the vendors and company profile, besides, Market price analysis and value chain features are covered in this report.
In Market segmentation by manufacturers, the report covers the following companies-
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
In Market segmentation by geographical regions, the report has analyzed the following regions- North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types covers:
Radium-223
Lutetium-177
Iodine-131
Other In Market segmentation by applications :
Thyroid
Bone Metastasis
Lymphoma
Other
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Therapeutic Radiopharmaceuticals Market for the forecast period 2020 - 2026?
• What are the driving forces in the Therapeutic Radiopharmaceuticals Market for the forecast period 2020 - 2026?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Therapeutic Radiopharmaceuticals industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players?
Table of Contents
Global Therapeutic Radiopharmaceuticals Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Therapeutic Radiopharmaceuticals Consumption 2015-2026
2.1.2 Therapeutic Radiopharmaceuticals Consumption CAGR by Region
2.2 Therapeutic Radiopharmaceuticals Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Radiopharmaceuticals Consumption by Type
2.3.1 Global Therapeutic Radiopharmaceuticals Consumption Market Share by Type (2015-2019)
2.3.2 Global Therapeutic Radiopharmaceuticals Revenue and Market Share by Type (2015-2019)
2.3.3 Global Therapeutic Radiopharmaceuticals Sale Price by Type (2015-2019)
2.4 Therapeutic Radiopharmaceuticals Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Radiopharmaceuticals Consumption by Application
2.5.1 Global Therapeutic Radiopharmaceuticals Consumption Market Share by Application (2015-2019)
2.5.2 Global Therapeutic Radiopharmaceuticals Value and Market Share by Application (2015-2019)
2.5.3 Global Therapeutic Radiopharmaceuticals Sale Price by Application (2015-2019)
3 Global Therapeutic Radiopharmaceuticals by Players
3.1 Global Therapeutic Radiopharmaceuticals Sales Market Share by Players
3.1.1 Global Therapeutic Radiopharmaceuticals Sales by Players (2018-2019)
3.1.2 Global Therapeutic Radiopharmaceuticals Sales Market Share by Players (2018-2019)
3.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Players
3.2.1 Global Therapeutic Radiopharmaceuticals Revenue by Players (2018-2019)
3.2.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Players (2018-2019)
3.3 Global Therapeutic Radiopharmaceuticals Sale Price by Players
3.4 Global Therapeutic Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Therapeutic Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Therapeutic Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Therapeutic Radiopharmaceuticals by Regions
4.1 Therapeutic Radiopharmaceuticals by Regions
4.1.1 Global Therapeutic Radiopharmaceuticals Consumption by Regions
4.1.2 Global Therapeutic Radiopharmaceuticals Value by Regions
4.2 Americas Therapeutic Radiopharmaceuticals Consumption Growth
4.3 APAC Therapeutic Radiopharmaceuticals Consumption Growth
4.4 Europe Therapeutic Radiopharmaceuticals Consumption Growth
4.5 Middle East & Africa Therapeutic Radiopharmaceuticals Consumption Growth
5 Americas
5.1 Americas Therapeutic Radiopharmaceuticals Consumption by Countries
5.1.1 Americas Therapeutic Radiopharmaceuticals Consumption by Countries (2015-2019)
5.1.2 Americas Therapeutic Radiopharmaceuticals Value by Countries (2015-2019)
5.2 Americas Therapeutic Radiopharmaceuticals Consumption by Type
5.3 Americas Therapeutic Radiopharmaceuticals Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Therapeutic Radiopharmaceuticals Consumption by Countries
6.1.1 APAC Therapeutic Radiopharmaceuticals Consumption by Countries (2015-2019)
6.1.2 APAC Therapeutic Radiopharmaceuticals Value by Countries (2015-2019)
6.2 APAC Therapeutic Radiopharmaceuticals Consumption by Type
6.3 APAC Therapeutic Radiopharmaceuticals Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Therapeutic Radiopharmaceuticals by Countries
7.1.1 Europe Therapeutic Radiopharmaceuticals Consumption by Countries (2015-2019)
7.1.2 Europe Therapeutic Radiopharmaceuticals Value by Countries (2015-2019)
7.2 Europe Therapeutic Radiopharmaceuticals Consumption by Type
7.3 Europe Therapeutic Radiopharmaceuticals Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Therapeutic Radiopharmaceuticals by Countries
8.1.1 Middle East & Africa Therapeutic Radiopharmaceuticals Consumption by Countries (2015-2019)
8.1.2 Middle East & Africa Therapeutic Radiopharmaceuticals Value by Countries (2015-2019)
8.2 Middle East & Africa Therapeutic Radiopharmaceuticals Consumption by Type
8.3 Middle East & Africa Therapeutic Radiopharmaceuticals Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
11 Global Therapeutic Radiopharmaceuticals Market Forecast
11.1 Global Therapeutic Radiopharmaceuticals Consumption Forecast (2020-2026)
11.2 Global Therapeutic Radiopharmaceuticals Forecast by Regions
11.2.1 Global Therapeutic Radiopharmaceuticals Forecast by Regions (2020-2026)
11.2.2 Global Therapeutic Radiopharmaceuticals Value Forecast by Regions (2020-2026)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Therapeutic Radiopharmaceuticals Forecast by Type
11.8 Global Therapeutic Radiopharmaceuticals Forecast by Application
12 Key Players Analysis
12.1 Bayer
12.1.1 Company Details
12.1.2 Therapeutic Radiopharmaceuticals Product Offered
12.1.3 Bayer Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2019)
12.1.4 Main Business Overview
12.1.5 Bayer News
12.2 Novartis
12.2.1 Company Details
12.2.2 Therapeutic Radiopharmaceuticals Product Offered
12.2.3 Novartis Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2019)
12.2.4 Main Business Overview
12.2.5 Novartis News
12.3 China Isotope & Radiation
12.3.1 Company Details
12.3.2 Therapeutic Radiopharmaceuticals Product Offered
12.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2019)
12.3.4 Main Business Overview
12.3.5 China Isotope & Radiation News
12.4 Dongcheng
12.4.1 Company Details
12.4.2 Therapeutic Radiopharmaceuticals Product Offered
12.4.3 Dongcheng Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2019)
12.4.4 Main Business Overview
12.4.5 Dongcheng News
12.5 Q BioMed
12.5.1 Company Details
12.5.2 Therapeutic Radiopharmaceuticals Product Offered
12.5.3 Q BioMed Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2019)
12.5.4 Main Business Overview
12.5.5 Q BioMed News
12.6 Curium Pharmaceuticals
12.6.1 Company Details
12.6.2 Therapeutic Radiopharmaceuticals Product Offered
12.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2019)
12.6.4 Main Business Overview
12.6.5 Curium Pharmaceuticals News
12.7 Jubilant DraxImage
12.7.1 Company Details
12.7.2 Therapeutic Radiopharmaceuticals Product Offered
12.7.3 Jubilant DraxImage Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2019)
12.7.4 Main Business Overview
12.7.5 Jubilant DraxImage News
12.8 Lantheus
12.8.1 Company Details
12.8.2 Therapeutic Radiopharmaceuticals Product Offered
12.8.3 Lantheus Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2019)
12.8.4 Main Business Overview
12.8.5 Lantheus News
12.9 Spectrum Pharmaceuticals
12.9.1 Company Details
12.9.2 Therapeutic Radiopharmaceuticals Product Offered
12.9.3 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2019)
12.9.4 Main Business Overview
12.9.5 Spectrum Pharmaceuticals News
12.10 Progenics Pharmaceuticals
12.10.1 Company Details
12.10.2 Therapeutic Radiopharmaceuticals Product Offered
12.10.3 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2019)
12.10.4 Main Business Overview
12.10.5 Progenics Pharmaceuticals News
12.11 International Isotopes
13 Research Findings and Conclusion
Research Methodology
The Reports Insights offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Reports Insights assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Reports Insights provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
I am completely satisfied with the information given in the report. Report Insights is a value driven company just like us.
Privacy requested , Managing Director
Reports Insights have understood our exact need and Delivered a solution for our requirements. Our experience with them has been fantastic.
Privacy requested, President
Report of Reports Insight has given us the ability to compete with our competitors, every dollar we spend with Reports Insights is worth every penny Reports Insights have given us a robust solution.
